Phacilitate Leaders World 

The Clinician's Perspective on Patient Access

The Clinician's Perspective on Patient Access

The realities of administering advanced therapies in the clinic is our industry's next big challenge. So, what is the clinician's perspective on what's needed to effectively and safely bring advanced therapies to patients?

Professor Marc Turner, professor of Cellular Therapy and Medical Director at the Scottish National Blood Transfusion Service and Dr Maria Pia Cicalese, IRCCS San Raffaele gave us their insight and answered the following questions in this video...

  1. What is the scale of the clinical need for ATMPs?
  2. Are specific centres of excellence the answer to patient access?
  3. How can ATMP manufacturers simplify product handling in the clinic?
  4. What role can clinicians play in securing funding for advanced therapies?



  • Real thinking forward combining experts in the field from manufacturing, regulatory and value vision” – “great network with strong experience and sharing risks & opportunities
    Anne-Virginie Eggimann
    bluebird bio
  • Great program, great people, great venue.
    Klaus Kühlcke
  • Dynamic, interesting and highly interactive event that promotes exchange and networking in highly specialized field of gene therapy.
    Nathalie Clement
    Powell Gene Therapy Center, University of Florida
  • Phacilitate provides a unique forum, bringing together research, process development, and commercial leaders on the cutting edge of cell, gene, and immunotherapy. A great conference for anyone wanting a comprehensive view of the field.
    Dr James Trager
  • It was all business. I’ve never been to an event where over 80% of the conversations I had were constructive to my business objectives.
    Kurt Gielen
    Chemelot Campus B.V.
  • Great way to expand network with global experts in cell and gene therapy who are facing similar challenges.
    Steven Goodman